Literature DB >> 7806443

Hepatitis C updated.

M J Whelton1, J Power, E Kenny-Walsh.   

Abstract

Mesh：

Year:  1994        PMID： 7806443     DOI： 10.1007/bf02967095

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  15 in total

1.  Hepatitis C among health care providers: risk factors and possible prophylaxis.

Authors:  E R Schiff
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

2.  The pathology of hepatitis C.

Authors:  P J Scheuer; P Ashrafzadeh; S Sherlock; D Brown; G M Dusheiko
Journal:  Hepatology       Date:  1992-04       Impact factor: 17.425

3.  Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.

Authors:  J H Hoofnagle; K D Mullen; D B Jones; V Rustgi; A Di Bisceglie; M Peters; J G Waggoner; Y Park; E A Jones
Journal:  N Engl J Med       Date:  1986-12-18       Impact factor: 91.245

4.  Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  JAMA       Date:  1967-05-01       Impact factor: 56.272

5.  Mooren's corneal ulcers and hepatitis C virus infection.

Authors:  S E Wilson; W M Lee; C Murakami; J Weng; G A Moninger
Journal:  N Engl J Med       Date:  1993-07-01       Impact factor: 91.245

6.  Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.

Authors:  R Misiani; P Bellavita; D Fenili; O Vicari; D Marchesi; P L Sironi; P Zilio; A Vernocchi; M Massazza; G Vendramin
Journal:  N Engl J Med       Date:  1994-03-17       Impact factor: 91.245

7.  Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.

Authors:  S Fargion; A Piperno; M D Cappellini; M Sampietro; A L Fracanzani; R Romano; R Caldarelli; R Marcelli; L Vecchi; G Fiorelli
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

8.  Response to interferon alpha therapy is influenced by the iron content of the liver.

Authors:  D H Van Thiel; L Friedlander; S Fagiuoli; H I Wright; W Irish; J S Gavaler
Journal:  J Hepatol       Date:  1994-03       Impact factor: 25.083

9.  Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.

Authors:  U Protzer; F R Ochsendorf; A Leopolder-Ochsendorf; K H Holtermüller
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

Review 10.  Antiviral therapy of hepatitis C--present and future.

Authors:  J H Hoofnagle; A M Di Bisceglie; M Shindo
Journal:  J Hepatol       Date:  1993       Impact factor: 25.083
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.